CoChat
Sign Up
Cited by 54Health Systems, Economic Evaluations, Quality of LifeHIV/AIDS Research and InterventionsHIV-related health complications and treatments

The DOI matches its Crossref record, with a small difference in title or year; 2 of the 2 references it cites were found in a registry or an index.

Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease.

Open access
Jim Shahriar, Thomas Delate, Ron D. Hays, Stephen Joel Coons·2003·Health and Quality of Life Outcomes
DOI 10.1186/1477-7525-1-25PMC PMC183842
Open this paper in CoChat — free accountOpen PDF

Abstract

The purpose was to compare and comment on use of the SF-36 and MOS-HIV instruments in studies of persons with HIV disease. Three medical information databases were searched to identify examples of HIV studies that included the MOS-HIV or SF-36. Thirty-nine and 14 published articles were identified for illustration in comparing the use of the MOS-HIV and SF-36 in HIV disease, respectively. Support for the reliability and construct validity of the MOS-HIV and SF-36 was found. Ceiling and floor effects were reported for both the MOS-HIV and SF-36; however, ceiling effects were more common for the MOS-HIV, in part due to fewer items in the physical, social, and role functioning domains. The MOS-HIV measures three domains hypothesized to be associated with the health deterioration of HIV disease not measured by the SF-36; however, these domains may not assess aspects of HIV disease that typify the majority of the persons with HIV disease today. National norms for the U.S. adult population (and other nations) are available for the SF-36. In addition, the SF-36 has been used in a wide variety of patient populations, enabling comparisons of HIV-infected persons with persons with other health conditions. No national norms for the MOS-HIV are available. We conclude that there is currently insufficient evidence in the literature to recommend the use of the MOS-HIV over the SF-36 in HIV-infected persons. Although the SF-36 is not targeted at HIV, it may be preferable to use the SF-36 over the MOS-HIV due to fewer ceiling effects, availability of national norms, and the vast amount of data for other populations in the U.S. and around the world. Head-to-head comparisons demonstrating the unique value of the MOS-HIV over the SF-36 are clearly needed. More importantly, additional work needs to be directed at comparing the MOS-HIV and other putatively HIV-targeted instruments to one another to help demarcate aspects of HRQOL that are truly generic versus specific to HIV disease. Using both a generic and targeted HRQOL measure is a good general strategy, but this has not been a typical practice in studies of HIV because the MOS-HIV is so similar in content to the SF-36.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7525-1-25

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 70

  1. Hays RD Shapiro MF An overview of generic health-related quality of life measures for HIV research Qual Life Res 1992 1 91 97 1301123
  2. de Boer JB van Dam FS Sprangers MA Health-related quality-of-life evaluation in HIV-infected patients. A review of the literature Pharmacoeconomics 1995 8 291 304 10155671
  3. Paltiel AD Stinnett AA Spilker B AIDS Quality of life and pharmacoeconomics in clinical trials 1996 Philadelphia: Lippincott-Raven Publishers 1053 1062
  4. Torres RA Barr M Impact of combination therapy for HIV infection on inpatient census N Engl J Med 1997 336 1531 1532 9157292
  5. Hirschel B Francioli P Progress and problems in the fight against AIDS N Engl J Med 1998 338 906 908 9516228
  6. Bozzette SA Hays RD Berry SH Kanouse DE A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity Med Care 1994 32 716 731 8028406
  7. Davis EA Pathak DS Psychometric evaluation of four HIV disease-specific quality-of-life instruments Ann Pharmacother 2001 35 546 552 11346059
  8. Stewart AL Hays RD Ware JE Jr The MOS short-form general health survey. Reliability and validity in a patient population Med Care 1988 26 724 735 3393032
  9. Tarlov AR Ware JE Jr Greenfield S Nelson EC Perrin E Zubkoff M The Medical Outcomes Study. An application of methods for monitoring the results of medical care JAMA 1989 262 925 930 2754793
  10. Wu AW Rubin HR Mathews WC Ware JE Jr Brysk LT Hardy WD A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection Med Care 1991 29 786 798 1875745
  11. Wachtel T Piette J Mor V Stein M Fleishman J Carpenter C Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument Ann Intern Med 1992 116 129 137 1727616
  12. Wu AW Revicki DA Jacobson D Malitz FE Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) Qual Life Res 1997 6 481 493 9330549
  13. Revicki DA Sorensen S Wu AW Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey Med Care 1998 36 126 137 9475468
  14. Ware JE Jr Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992 30 473 483 1593914
  15. Ware J Jr Kosinski M Keller SD A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 1996 34 220 233 8628042
  16. Bing EG Hays RD Jacobson LP Chen B Gange SJ Kass Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study Qual Life Res 2000 9 55 63 10981206
  17. Copfer AE Ampel NM Hughes TE Gregor KJ Dols CL Coons SJ The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison Qual Life Res 1996 5 281 286 8998497
  18. Badia X Podzamczer D Garcia M Lopez-Lavid CC Consiglio E A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQOL-HIV Validation Group. Medical Outcomes Study HIV Health Survey AIDS 1999 13 1727 1735 10509575
  19. Badia X Podzamczer D Lopez-Lavid C Garcia M Evidence-based medicine and the validation of quality-of-life questionnaires: the Spanish version of the MOS-HIV questionnaire for the evaluation of the quality of life in patients infected by HIV Enferm Infecc Microbiol Clin 1999 17 103 13 10605195
  20. Badia X Podzamczer D Casado A Lopez-Lavid C Garcia M Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV Validation Group AIDS 2000 14 1439 1447 10930160
  21. Bayoumi AM Redelmeier DA Economic methods for measuring the quality of life associated with HIV infection Qual Life Res 1999 8 471 480 10548862
  22. Burgess AP Dayer M Catalan J Hawkins D The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis AIDS 1993 7 1008 8357546
  23. Carretero MD Burgess AP Soler P Soler M Catalan J Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users AIDS 1996 10 1699 1705 8970691
  24. Chan KS Revicki DA Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus Eval Health Prof 1998 21 265 281 10183347
  25. Chatterton ML Scott-Lennox J Wu AW Scott J Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection Pharmacoeconomics 1999 15 67 74 10537443
  26. Cohen C Revicki DA Nabulsi A Sarocco PW Jiang P A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group AIDS 1998 12 1495 1502 9727571
  27. Cunningham WE Bozzette SA Hays RD Kanouse DE Shapiro MF Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts Med Care 1995 33 AS15 AS25 7723442
  28. Delate T Coons SJ The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV Clin Ther 2000 22 1112 1120 11048908
  29. Gold J High HA Li Y Michelmore H Bodsworth NJ Finlayson R Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection AIDS 1996 10 745 752 8805865
  30. Heald AE Pieper CF Schiffman SS Taste and smell complaints in HIV-infected patients AIDS 1998 12 1667 1674 9764787
  31. Holmes WC Shea JA Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV Qual Life Res 1999 8 515 527 10548867
  32. Hughes TE Kaplan RM Coons SJ Draugalis JR Johnson JA Patterson TL Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients Med Decis Making 1997 17 439 446 9343802
  33. Murri R Ammassari A Fantoni M Scoppettuolo G Cingolani A De Luca A Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey J Acquir Immune Defic Syndr Hum Retrovirol 1997 16 350 356 9420313
  34. Murri R Fantoni M Del Borgo C Izzi I Visona R Suter F Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors J Acquir Immune Defic Syndr 1999 22 461 466 10961607
  35. Nieuwkerk PT Gisolf EH Colebunders R Wu AW Danner SA Sprangers MA Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group AIDS 2000 14 181 187 10708289
  36. O'Leary JF Ganz PA Wu AW Coscarelli A Petersen L Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES) J Acquir Immune Defic Syndr Hum Retrovirol 1998 17 433 441 9562046
  37. Raboud JM Singer J Thorne A Schechter MT Shafran SD Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death Qual Life Res 1998 7 487 494 9737138
  38. Revicki DA Wu AW Murray MI Change in clinical status, health status, and health utility outcomes in HIV-infected patients Med Care 1995 33 AS173 AS182 7723445
  39. Revicki DA Swartz C Wu AW Haubrich R Collier AC Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3 Antivir Ther 1999 4 35 44 10682127
  40. Revicki DA Moyle G Stellbrink HJ Barker C Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group AIDS 1999 13 851 858 10357386
  41. Schag CA Ganz PA Kahn B Petersen L Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES) Qual Life Res 1992 1 397 413 1299472
  42. Scott-Lennox JA Mills RJ Burt MS Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life Ann Pharmacother 1998 32 525 530 9606471
  43. Weinfurt KP Willke RJ Glick HA Freimuth WW Schulman KA Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients Med Care 2000 38 404 410 10752972
  44. Wu AW Jacobson DL Berzon RA Revicki DA van der HC Fichtenbaum CJ The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS Qual Life Res 1997 6 3 10 9062436
  45. Wu AW Quality of life assessment comes of age in the era of highly active antiretroviral therapy AIDS 2000 14 1451 10930161
  46. Marinacci C Schifano P Borgia P Perucci CA Application of random effect ordinal regression model for outcome evaluation of two randomized controlled trials Stat Med 2001 20 3769 3776 11782032
  47. Knippels HM Goodkin K Weiss JJ Wilkie FL Antoni MH The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale AIDS 2002 16 259 267 [erratum appears in AIDS 2002 Mar 8;16(4):681]. 11807311
  48. Miners AH Sabin CA Mocroft A Youle M Fisher M Johnson M Health-related quality of life in individuals infected with HIV in the era of HAART HIV Clin Trials 2001 2 484 492 11742437
  49. Casado A Consiglio E Podzamczer D Badia X Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients HIV Clin Trials 2001 2 477 483 11742436
  50. Turner J Page-Shafer K Chin DP Osmond D Mossar M Markstein L Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection AIDS Patient Care and STDs 2001 15 615 624 11788076
  51. Piketty C Jayle D Leplege A Castiel P Ecosse E Gonzalez-Canali G Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease Clin Endocrinol 2001 55 325 330 11589675
  52. Blanch J Martinez E Rousaud A Blanco JL Garcia-Viejo MA Peri JM Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz J Acquir Immune Defic Syndr 2001 27 336 343 11468421
  53. Scott-Lennox JA Wu AW Boyer JG Ware JE Jr Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey Med Care 1999 37 908 925 10493469
  54. Call SA Klapow JC Stewart KE Westfall AO Mallinger AP DeMasi RA Health-related quality of life and virologic outcomes in an HIV clinic Qual Life Res 2000 9 977 985 11332226
  55. Anderson JP Kaplan RM Coons SJ Schneiderman LJ Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses J Clin Epidemiol 1998 51 755 762 9731924
  56. Arpinelli F Visona G Bruno R De Carli G Apolone G Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients Pharmacoeconomics 2000 18 63 72 11010605
  57. Bakken S Holzemer WL Brown MA Powell-Cope GM Turner JG Inouye J Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS AIDS Patient Care and STDS 2000 14 189 197 10806637
  58. Bastardo YM Kimberlin CL Relationship between quality of life, social support and disease-related factors in HIV-infected persons in Venezuela AIDS Care 2000 12 673 684 11218552
  59. Bult JR Hunink MG Tsevat J Weinstein MC Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients Med Care 1998 36 523 532 9544592
  60. Miners AH Sabin CA Tolley KH Jenkinson C Ebrahim S Lee CA Assessing health-related quality-of-life in patients with severe haemophilia A and B Psychology, Health & Medicine 1999 4 15 10583523
  61. Miners AH Sabin CA Tolley KH Jenkinson C Kind P Lee CA Assessing health-related quality-of-life in individuals with haemophilia Haemophilia 1999 5 378 385 10583523
  62. O'Keefe EA Wood R The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population Qual Life Res 1996 5 275 280 8998496
  63. Swindells S Mohr J Justis JC Berman S Squier C Wagener MM Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness Int J STD AIDS 1999 10 383 391 10414881
  64. Tsevat J Solzan JG Kuntz KM Ragland J Currier JS Sell RL Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning Med Care 1996 34 44 57 8551811
  65. Burgoyne RW Saunders DS Quality of life among urban Canadian HIV/AIDS clinic outpatients Int J of STD AIDS 2001 12 505 512 11487390
  66. te Vaarwerk MJ Gaal EA Psychological distress and quality of life in drug-using and non-drug-using HIV-infected women Eur J Public Health 2001 11 109 115 11276564
  67. Delate T Coons SJ The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus Clin Infect Dis 2001 32 e47 e52 11170970
  68. Hays RD Cunningham WE Sherbourne CD Wilson IB Wu AW Cleary PD Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study Am J Med 2000 108 714 722 10924648
  69. Singer J Thorne A Khorasheh S Raboud JM Wu AW Salit I Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group Int J STD AIDS 2000 11 212 219 10772083
  70. Bindman AB Keane D Lurie N Measuring health changes among severely ill patients. The floor phenomenon Med Care 1990 28 1142 1152 2250498

Cited by

Sorted by citations

Metadata

Authors
Shahriar, J., Delate, T., Hays, R. D., & Coons, S. J.
Affiliations
  • Blue Shield of California Foundation (US)
  • University of California, Los Angeles (US)
  • University of Arizona (US)
Corresponding author
Stephen Joel Coons
ORCID
Venue
Health and Quality of Life Outcomes
Publisher
Springer Science and Business Media LLC
Published
2003
Volume
1
Issue
1
Pages
25
ISSN
1477-7525 (ISSN-L)
DOI
10.1186/1477-7525-1-25
PMC
PMC183842
OpenAlex
W2117256080
Cited by
54
References
2
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 5
FWCI
6.46
Type
journal article
Language
en
Open access
Locations
  • Health and Quality of Life Outcomes (publishedVersion)
  • PubMed Central (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (acceptedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health (5p20md000148-05)
  • National Institute on Aging (AG-02-004)
  • National Institute on Minority Health and Health Disparities (P20-MD00148-01, P20-MD000148)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Keywords
SF-36, MOS-HIV, HIV infection, health-related quality of life, patient-reported outcome measures, ceiling effect, floor effect, construct validity, reliability statistics, national standards
MeSH terms
Female, Health Status, Health Surveys, Humans, Male, Psychometrics, Quality of Life, Surveys and Questionnaires, Reproducibility of Results, HIV Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review